692 results on '"Barletta G"'
Search Results
2. Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)
3. Cardiovascular reflex tests detect autonomic dysfunction in symptomatic and pre-symptomatic subjects with hereditary transthyretin amyloidosis
4. Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature
5. Defect-Driven topology optimization for fatigue design of additive manufacturing structures: Application on a real industrial aerospace component
6. Electrical overstress effect characterization on Power MOS Trenchfet and correlation with time dependent dielectric breakdown
7. Diastolic function is more sensitive than GLS in identifing cardiotoxicity. The SAFE trial results
8. The right ventricle is not spared by the cardiotoxic effects of chemotherapy for breast cancer. Results of SAFE trial
9. Cardioprotection beyond the guidelines: the SAFE trial results
10. Investigation of degradation mechanisms in low-voltage p-channel power MOSFETs under High Temperature Gate Bias stress
11. Cardiological Safety of 5-Fraction Whole Breast Irradiation
12. Site and type of craniopharyngiomas impact differently on 24-hour circadian rhythms and surgical outcome. A neurophysiological evaluation
13. AB0885 HIGH RESOLUTION IMPEDANCE MANOMETRY IN DERMATOMYOSITIS ALLOWS THE CHARACTERIZATION OF ESOPHAGEAL DYSMOTILITY AND THE PROFILING OF DIFFERENT CLINICAL AND SEROLOGICAL SUBSETS
14. PO-1269 Cardiological monitoring and safety of 5-fraction whole breast irradiation: SAFE-FORWARD study
15. Study of gate leakage mechanism in advanced charge-coupled MOSFET (CC-MOSFET) technology
16. Circulating PD-L1 and TIM3 as Prognostic Markers in Patients With Advanced Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor
17. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
18. 66P Outcome predictors for pembrolizumab alone or with chemotherapy in advanced non-small cell lung cancer (NSCLC)
19. Regular solutions for nonlinear elliptic equations, with convective terms, in Orlicz spaces
20. Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis
21. A new integrated instrumental approach to autonomic nervous system assessment
22. EP08.01-088 Direct Acting Antivirals (DAA) and Immune Checkpoint Inhibitors (ICIs) Therapy in Patients with Lung Cancer and Hepatitis C
23. 1043P Clinical predictors of benefit from pembrolizumab (pembro) or pembro-chemotherapy (CHT) in advanced non-small cell lung cancer (NSCLC)
24. EP08.02-046 Activity of OsimeRTInib in NSCLC with Uncommon EGFR Mutations: Retrospective Observational Multicenter Study (ARTICUNO)
25. 1897P Time to access to diagnosis and treatment for lung cancer (LC): Experience within an Italian comprehensive cancer center
26. Autonomic Nervous System: Clinical Testing ☆
27. OC-0935 Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis
28. The impact of vaccination status on post-acute sequelae in hospitalized COVID-19 survivors using a multi-disciplinary approach: An observational single center study
29. Role of microRNAs in malignant mesothelioma
30. Spectral analysis of heart rate variability reveals an enhanced sympathetic activity in narcolepsy with cataplexy
31. Intrinsically Disordered Region Modulates Ligand Binding in Glutaredoxin 1 from Trypanosoma Brucei
32. Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors
33. Central and cardiovascular responses to emotional stimuli are normal in non-phobic subjects with Reflex Syncope
34. ATLAS
35. The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population
36. 1456P Exploring biological and molecular factors as outcome predictors for pembrolizumab (Pem) or pembrolizumab-chemotherapy (Pem-CT) in advanced non-small cell lung cancer (NSCLC)
37. Poster Session Saturday 14 December - AM: 14/12/2013, 08: 30–12: 30Location: Poster area
38. Poster session Friday 13 December - PM: 13/12/2013, 14: 00–18: 00Location: Poster area
39. Poster session Thursday 12 December - PM: 12/12/2013, 14: 00–18: 00Location: Poster area
40. Cardiac autonomic tone during trandolapril-irbesartan low-dose combined therapy in hypertension: a pilot project
41. PRELIMINARY LIST OF MEDITERRANEAN OPISTHOBRANCH MOLLUSKS
42. EFFECTS OF VAGUS NERVE STIMULATION ON SEIZURES AND CARDIOVASCULAR RESPONSES IN PATIENTS WITH DRUG-RESISTANT EPILEPSY: p541
43. Post-ejection thickening as a marker of viable myocardium. An echocardiographic study in patients with chronic coronary artery disease
44. Cardiac autonomic modulation and incidence of late potentials in essential hypertension: role of age, sex, ventricular mass and remodeling
45. Parallel increase in carotid, brachial and left ventricular cross-sectional areas in arterial hypertension
46. Effect of deep brain stimulation of the posterior hypothalamic area on the cardiovascular system in chronic cluster headache patients
47. Cardiovascular autonomic dysfunction in normotensive awake subjects with obstructive sleep apnoea syndrome
48. 153 (PB-066) Poster - Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis
49. 1581P Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors (ICIs): Pooled analysis of individual cases from multiple institutions and literature
50. Effects of reconstructive surgery for left ventricular anterior aneurysm on ventriculoarterial coupling
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.